Follow us on Twitter

Get News Alerts

Thursday, October 12, 2017

Ebola vaccines from Merck, Glaxo show promise

  1. Ebola vaccines from Merck, Glaxo show promise  MarketWatch
  2. Liberia trial finds Ebola vaccines yield year-long immune response  CIDRAP
  3. Experimental Ebola vaccines elicit year-long immune response  National Institutes of HealthFull coverage

No comments:

Post a Comment

Headlines